tradingkey.logo
搜索

Privia Health Group Inc

PRVA
添加自选
25.970USD
+0.470+1.84%
交易中 美东报价延迟15分钟
3.26B总市值
146.48市盈率 TTM

关于 Privia Health Group Inc 公司

Privia Health Group, Inc. is a technology-driven, national physician-enablement company. The Company collaborates with medical groups, health plans and health systems. It enhances physician practices, improves patient experiences and doctors for delivering care in both in-person and virtual care settings. Its Privia Platform is powered by the Privia Technology Solution, an end-to-end, cloud-based technology solution that integrates both Privia-developed and third-party applications into an interface and workflow that manages all aspects of its Privia Providers provision of healthcare services. Privia Platform optimizes provider workflow across the full continuum of reimbursement arrangements. The Company provides management services to each Medical Group though a local management services organization, which provides Medical Groups with access to value-based care (VBC) opportunities either directly or through Privia-owned accountable care organizations.

Privia Health Group Inc简介

公司代码PRVA
公司名称Privia Health Group Inc
上市日期Apr 29, 2021
CEOMehrotra (Parth)
员工数量1140
证券类型Ordinary Share
年结日Apr 29
公司地址950 N. Glebe Rd., Suite 700
城市ARLINGTON
上市交易所NASDAQ OMX - NASDAQ BASIC
国家United States of America
邮编22203
电话15713668850
网址https://www.priviahealth.com/
公司代码PRVA
上市日期Apr 29, 2021
CEOMehrotra (Parth)

Privia Health Group Inc公司高管

名称
名称/职务
职务
持股
持股变动
Mr. David S. (Dave) Wichmann
Mr. David S. (Dave) Wichmann
Independent Director
Independent Director
1.33M
+0.20%
Mr. Parth Mehrotra
Mr. Parth Mehrotra
Chief Executive Officer, Director
Chief Executive Officer, Director
275.56K
-43.94%
Mr. David Mountcastle, CPA
Mr. David Mountcastle, CPA
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
131.22K
-35.52%
Dr. Jaewon Ryu, M.D.
Dr. Jaewon Ryu, M.D.
Independent Director
Independent Director
38.71K
+21.86%
Dr. Patricia Anne Maryland
Dr. Patricia Anne Maryland
Independent Director
Independent Director
31.19K
+26.92%
Mr. Lance V. Berberian
Mr. Lance V. Berberian
Independent Director
Independent Director
16.13K
+52.46%
Mr. Shawn Morris, CPA
Mr. Shawn Morris, CPA
Director
Director
--
--
Ms. Nancy G. Cocozza
Ms. Nancy G. Cocozza
Independent Director
Independent Director
--
--
Mr. David King
Mr. David King
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. Thomas A. (Tom) Mccarthy
Mr. Thomas A. (Tom) Mccarthy
Independent Director
Independent Director
--
--
查看更多
名称
名称/职务
职务
持股
持股变动
Mr. David S. (Dave) Wichmann
Mr. David S. (Dave) Wichmann
Independent Director
Independent Director
1.33M
+0.20%
Mr. Parth Mehrotra
Mr. Parth Mehrotra
Chief Executive Officer, Director
Chief Executive Officer, Director
275.56K
-43.94%
Mr. David Mountcastle, CPA
Mr. David Mountcastle, CPA
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
131.22K
-35.52%
Dr. Jaewon Ryu, M.D.
Dr. Jaewon Ryu, M.D.
Independent Director
Independent Director
38.71K
+21.86%
Dr. Patricia Anne Maryland
Dr. Patricia Anne Maryland
Independent Director
Independent Director
31.19K
+26.92%
Mr. Lance V. Berberian
Mr. Lance V. Berberian
Independent Director
Independent Director
16.13K
+52.46%

常见问题

Privia Health Group Inc的前五大股东是谁?

Privia Health Group Inc 的前五大股东如下:Mr. David S. (Dave) Wichmann

有多少机构持有Privia Health Group Inc(PRVA)的股份?

截至2026Q1,共有550家机构持有Privia Health Group Inc的股份,合计持有的股份价值约为134.16M,占公司总股份的106.47%。与2025Q4相比,机构持股有所增加,增幅为5682667.00。

哪个业务部门对Privia Health Group Inc的收入贡献最大?

在2026Q1,FFS-patient care业务部门对Privia Health Group Inc的收入贡献最大,创收1.36B,占总收入的64.08%。
tradingkey.logo
风险提示:我们的网站和移动应用程序仅提供关于某些投资产品的一般信息。Finsights 不提供财务建议或对任何投资产品的推荐,且提供此类信息不应被解释为 Finsights 提供财务建议或推荐。
投资产品存在重大投资风险,包括可能损失投资的本金,且可能并不适合所有人。投资产品的过去表现并不代表其未来表现。
Finsights 可能允许第三方广告商或关联公司在我们的网站或移动应用程序的任何部分放置或投放广告,并可能根据您与广告的互动情况获得报酬。
© 版权所有: FINSIGHTS MEDIA PTE. LTD. 版权所有